94 related articles for article (PubMed ID: 12843624)
1. Influence of liver disease on phenolsulfonphthalein absorption from liver surface to examine possibility of direct liver surface application for drug targeting.
Nishida K; Honda T; Nakashima M; Sasaki H; Nakamura J
Biol Pharm Bull; 2003 Jul; 26(7):988-93. PubMed ID: 12843624
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of phenol red in rat models of liver damage prepared by liver targeting of carbon tetrachloride.
Mukai T; Mera K; Nishida K; Nakashima M; Sasaki H; Nakamura J
Biol Pharm Bull; 2004 Apr; 27(4):595-7. PubMed ID: 15056875
[TBL] [Abstract][Full Text] [Related]
3. Absorption characteristics of compounds with different molecular weights after application to the unilateral kidney surface in rats.
Nishida K; Tomiyama N; Mukai T; Nakashima M; Sasaki H; Nakamura J
Eur J Pharm Biopharm; 2004 Nov; 58(3):705-11. PubMed ID: 15451548
[TBL] [Abstract][Full Text] [Related]
4. Effect of application volume and area on the absorption of phenol red, as a model drug, from the liver surface in rats.
Nishida K; Sato N; Nakakoga Y; Mukai T; Sasaki H; Nakamura J
J Pharm Pharmacol; 1997 Oct; 49(10):976-80. PubMed ID: 9364405
[TBL] [Abstract][Full Text] [Related]
5. Absorption of phenolsulfonphthalein as a model across the mesenteric surface in rats to determine the drug absorption route after intraperitoneal administration.
Nishida K; Nose S; Kuma A; Mukai T; Nakashima M; Sasaki H; Nakamura J
J Pharm Pharmacol; 2004 May; 56(5):683-7. PubMed ID: 15142348
[TBL] [Abstract][Full Text] [Related]
6. Regional delivery of model compounds and 5-Fluorouracil to the liver by their application to the liver surface in rats: its implication for clinical use.
Nishida K; Fujiwara R; Kodama Y; Fumoto S; Mukai T; Nakashima M; Sasaki H; Nakamura J
Pharm Res; 2005 Aug; 22(8):1331-7. PubMed ID: 16078143
[TBL] [Abstract][Full Text] [Related]
7. Delivery advantage to the unilateral kidney by direct drug application to the kidney surface in rats and pharmacokinetic verification based on a physiological model.
Nishida K; Kamenosono M; Kuma A; Fumoto S; Mukai T; Nakashima M; Sasaki H; Nakamura J
J Drug Target; 2005 May; 13(4):215-23. PubMed ID: 16051533
[TBL] [Abstract][Full Text] [Related]
8. Absorption characteristics of model compounds with different molecular weights from the serosal caecal surface in rats.
Nishida K; Nose S; Kuma A; Mukai T; Kawakami S; Nakashima M; Sasaki H; Sakaeda T; Nakamura J
J Pharm Pharmacol; 2002 Jul; 54(7):1005-9. PubMed ID: 12162704
[TBL] [Abstract][Full Text] [Related]
9. Mechanism for drug absorption from rat-liver surface membrane: effect of dose and transport inhibitors on the pharmacokinetics of phenol red.
Nishida K; Sato N; Sasaki H; Nakamura J
J Pharm Pharmacol; 1995 Mar; 47(3):227-31. PubMed ID: 7602486
[TBL] [Abstract][Full Text] [Related]
10. Effect of instillation method on the absorption of phenolsulphonphthalein as a model drug from the liver and small intestinal serosal surface in rats.
Nishida K; Yoshida Y; Mukai T; Kawakami S; Sakaeda T; Nakashima M; Sasaki H; Nakamura J
J Pharm Pharmacol; 2001 Oct; 53(10):1341-6. PubMed ID: 11697541
[TBL] [Abstract][Full Text] [Related]
11. Influence of Liver Intoxication by Carbon Tetrachloride or D-Galactosamine on Absorption of Fluorescein Isothiocyanate-Dextran-10 and Other Marker Compounds with Different Molecular Weights from the Rat Liver Surface.
Miyamoto H; Tsuda K; Honda T; Tokunaga A; Fumoto S; Nishida K
Biol Pharm Bull; 2020; 43(2):319-324. PubMed ID: 32009118
[TBL] [Abstract][Full Text] [Related]
12. Absorption of phenol red and bromphenol blue as model drugs from the peritoneal cavity around the liver surface in rats.
Nishida K; Amagishi H; Sasaki H; Nakamura J
J Pharm Pharmacol; 1995 Dec; 47(12A):1032-5. PubMed ID: 8932690
[TBL] [Abstract][Full Text] [Related]
13. Absorption characteristics of model compounds from the small intestinal serosal surface and a comparison with other organ surfaces.
Nishida K; Kuma A; Fumoto S; Nakashima M; Sasaki H; Nakamura J
J Pharm Pharmacol; 2005 Aug; 57(8):1073-7. PubMed ID: 16102265
[TBL] [Abstract][Full Text] [Related]
14. Absorption of organic anions as model drugs following application to rat liver surface in-vivo.
Nishida K; Sato N; Sasaki H; Nakamura J
J Pharm Pharmacol; 1994 Nov; 46(11):867-70. PubMed ID: 7897589
[TBL] [Abstract][Full Text] [Related]
15. Continuous microinstillation of phenol red on liver surface for liver site-selective delivery.
Nakamura J; Yoshida Y; Mera K; Mukai T; Nishida K; Sasaki H
Biol Pharm Bull; 1999 Jul; 22(7):713-5. PubMed ID: 10443468
[TBL] [Abstract][Full Text] [Related]
16. Effect of viscous additives on drug absorption from the liver surface in rats using phenol red as a model.
Nishida K; Nakakoga Y; Sato N; Kawakami S; Mukai T; Sasaki H; Sakaeda T; Nakamura J
Eur J Pharm Biopharm; 2000 Nov; 50(3):397-402. PubMed ID: 11072197
[TBL] [Abstract][Full Text] [Related]
17. Effect of intestinal atrophy and hepatic impairment induced by parenteral nutrition on drug absorption and disposition in rats.
Fukushima K; Miki T; Nakamoto K; Nishimura A; Koyama H; Ichikawa H; Shibata N; Tokuyama S; Sugioka N
JPEN J Parenter Enteral Nutr; 2015 Feb; 39(2):218-27. PubMed ID: 23894177
[TBL] [Abstract][Full Text] [Related]
18. Ketoprofen glucuronidation and bile excretion in carbon tetrachloride and alpha-naphthylisothiocyanate induced hepatic injury rats.
Zhao Y; Zhai D; Chen X; Yang J; Song X; He H; Yu Q; Xing Y
Toxicology; 2007 Feb; 230(2-3):145-50. PubMed ID: 17184895
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic analysis of the absorption enhancing action of decanoic acid and its derivatives in rats.
Takahashi K; Murakami T; Kamata A; Yumoto R; Higashi Y; Yata N
Pharm Res; 1994 Mar; 11(3):388-92. PubMed ID: 8008704
[TBL] [Abstract][Full Text] [Related]
20. [Adrenaline inactivation capacity of normal liver and CCl-4 intoxicated liver (perfused in vitro)].
Costiner E; Vaisler L; Chivu V
Stud Cercet Endocrinol; 1966; 17(4):355-7. PubMed ID: 6010410
[No Abstract] [Full Text] [Related]
[Next] [New Search]
